Bioceramed
10
4
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
40.0%
4 terminated/withdrawn out of 10 trials
20.0%
-66.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Evaluation of the Safety and Performance of the Neocement® Inject P
Role: lead
Evaluation of the Safety and Performance of the TriOSS®: A Retrospective Observational Study in Orthopaedic Area
Role: lead
Evaluation of the Safety and Performance of the Neocement®
Role: lead
Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area
Role: lead
Evaluation of the Safety and Performance of the Neobone®: A Prospective Observational Study in Dental Area
Role: lead
Evaluation of the Safety and Performance of the TriOSS®: A Prospective Observational Study in Dental Area
Role: lead
RETROSPECTIVE COLLECTION OF SAFETY AND PERFORMANCE DATA - 2023.02
Role: lead
Prospective Multicenter Observational Study on the Use of NEOCEMENT® for the Treatment of Bone Defects
Role: lead
Calcium Phosphate Cement As Bone Void Filler
Role: lead
Retrospective Collection of Safety and Performance Data
Role: lead
All 10 trials loaded